Background: p75 NTR has been used to isolate esophageal and corneal epithelial stem cells. In the present study, we investigated the expression of p75 NTR in esophageal squamous cell carcinoma (ESCC) and explored the biological properties of p75 NTR+ cells.
Background
The "cancer stem cell" theory has aroused increasing interest in the field of oncology [1] [2] [3] [4] . According to this theory, cancer stem cells (CSCs), which account for a very small proportion of tumor tissue, have the self-renewal property typical of normal stem cells. CSCs rarely divide, but they are able to produce fast-proliferating daughter cells. Previous studies have demonstrated the existence of CSCs in a variety of tumors including liver carcinoma [5, 6] , brain tumors [1, 2] , breast carcinoma [7] , lung carcinoma [8] , colorectal carcinoma [9] , pancreatic carcinoma [10] , and thyroid tumors [11] . In addition to the basic stem cell properties, CSCs also display high resistance to radiation and conventional chemotherapy. Bao et al [12] reported that CD133 positive CSCs contributed to glioma radioresistance through preferential activation of DNA damage checkpoint response and increased capacity of DNA repair. Liu et al [13] also reported that CD133 positive CSCs in brain glioblastoma showed strong chemoresistance attributable to higher expression of ABCG2 and MGMT. These studies strongly support the cancer stem cell theory that CSCs are the underlying cause of recurrence and metastasis of tumors.
Low-affinity neurotrophin receptor (p75 NTR ), a member of tumor necrosis factor superfamily [14, 15] , has been shown to paradoxically mediate neuronal survival and differentiation or apoptotic cell death, depending on the environment of the cells [16] . Okumura et al [17] reported that p75 NTR+ esophageal epithelial cells were stem cells due to their capacity of proliferation, selfrenewal and multidirectional differentiation. p75 NTR was also used for screening mouse testis peritubular smooth muscle precursors [18] , rat fat multipotential stem cells [19] , and human corneal epithelial progenitor cells [20] . In the present study, we found that p75 NTR+ esophageal squamous cell carcinomas (ESCC) cells exhibited properties of CSCs in terms of self-renewal and chemotherapy resistance.
Methods

ESCC specimens and immunohistochemistry
A total of 100 patients with histopathologically confirmed ESCC who underwent surgery at Changhai Hospital between 2005 and 2006 were selected. Informed consent was obtained from the patients or their guardians. No preoperative history of radio-therapy or chemotherapy was reported in any of the patients.
Antibodies used in this study included: mouse anti human p75 NTR (Upstate Corporation, USA), involucrin (Santa cruz Corporation, USA), p63 (DAKO Corporation, Denmark) and ki-67 (DAKO Corporation, Denmark). For antigen retrieval, the slides were treated with boiling 10 mM citrate buffer (pH 6.0) for 25 min. Immunohisto-chemical staining was performed using EnVision™ Kit (HRP, DAKO Corporation, Denmark). All slides were evaluated independently by two investigators (XHL. and CGB.) without prior knowledge of the clinical information of the patients. The samples were divided into two groups according to the percentage of p75 NTR stainingpositive cells, tumors were classified as positive if >10% tumor cells were stained and negative if ≤ 10% tumor cells were stained [21] . The ki-67 index was defined as the percentage of ki-67 positive tumor cell nuclei.
Cell source and culture condition
Esophageal carcinoma cell line Eca109 was purchased from Shanghai Cell Biology Institute of the Chinese Academy of Sciences. Eca109-eGFP was established by lentiviral vector (Invitrogen Corporation, USA). Cells were cultured in DMEM containing 10% fetal bovine serum at 37°C, 5% CO 2 . Three cell lines (SHEC-1, SHEC-4 and SHEC-5) were newly established. In brief, surgically removed fresh specimens were rinsed with serum-free RPMI-1640 (Invitrogen Corporation, USA) for 3 times, cut into 1 mm 3 tissue masses and incubated in enzymatic dissociation in DMEM containing 1 mg/mL collagenase IV (Invitrogen Corporation, USA) for 4-6 h at 37°C. The isolated cells were cultured in DMEM containing 10% fetal bovine serum in a humidified 5% CO 2 atmosphere at 37°C. Three cell lines were established by serial passage and designated SHEC-1, SHEC-4 and SHEC-5, respectively.
Flow cytometry and fluorescence-activated cell sorting
Tumor cells were harvested and adjusted to a concentration of 1 × 10 6 cells/ml with Buffer1 (phosphate buffered saline containing 0.5% bovine serum albumin and 2 mM EDTA). The cells were incubated with primary antibody for 2 h at 4°C. After washing with Buffer1 twice, the cells were resuspended in 500 μl Buffer1, to which PE-conjugated goat anti mouse IgG (BD PharMingen Corporation, USA) was added. The samples were then incubated away from light for 15 min at 4°C. Following staining, the samples were analyzed using a FACSCalibur flow cytometer and CellQuest software (BD Biosciences, San Jose, CA). Primary antibodies were: mouse anti human p75 NTR , involucrin, β1-integrin (Santa cruz Corporation, USA) and cytokeratin 13 (Santa cruz Corporation, USA). Fluorescence-activated cell sorting (FACS) of p75 NTR+ and p75 NTRcells was performed on a Cytomation MoFlo cytometer (DakoCytomation Corporation, Denmark). The top 25% most brightly stained cells were isolated as p75 NTR+ cells. Cells incubated with PE-conjugated antibodies were used as controls.
RNA isolation and cDNA synthesis
Total RNA of tumor cells was extracted by RNA4PCR kit (Amibion Corporation, USA) according to the manufac-turer's instructions. RNA was dissolved in 50 μl distilled water containing 0.1% diethylpyrocarbonate and quantitated at OD 260 by spectrophotometry.
Real-time quantitative reverse transcription-PCR
Total RNA was used as the template to amplify Bmi-1, p63, involucrin, cytokeratin 13, β1-integrin and β4integrin and CTR1 by real-time quantitative reverse transcription-PCR (real-time qPCR). G6PDH was used as internal control. The following primer sequences were used, and expected product sizes were noted in parentheses. 
Sphere formation assay
Tumor cells were resuspended to 1 × 10 4 cells/ml in serum-free medium (keratinocyte-SFM medium, with addition of penicillin 100 IU/ml, streptomycin 100 μg/ ml, epidermal growth factor 5 ng/ml, bovine pituitary extract 70 μg/ml, hydrocortisonum 0.5 μg/ml and regular insulin 5 μg/ml in sequence). The cultures were monitored for the sphere formation within 3 weeks. To passage the spheres, medium was aspirated off and spheres were harvested with the TransferMan NK 2 micromanipulator (Eppendorf). After trypsin digestion, single cell suspension was prepared by mechanical dissociation. To determine the differentiation of p75 NTR+ cells, single viable floating p75 NTR+ cells were collected and resuspended to 1 × 10 3 cells/mL in keratinocyte-SFM medium containing 10% fetal bovine serum. The expression of involucrin and cytokeratin 13 was detected by immunocytochemistry.
DDP sensitivity assay
Stock solution of 1 mg/ml DDP (Sigma-Aldrich, USA) was prepared in dimethylformamide and stored at -20°C for no longer than 3 days. Isolated p75 NTR+ and p75 NTRcells were seeded into 96-well culture plates (5 × 10 2 cells/well) respectively, and incubated in an atmosphere containing 5% CO 2 for 24 h at 37°C. In our pilot study, DDP inhibited the viability of Eca109 cells in a concentrationdependent manner with an apparent IC10 value of 0.23 μg/ml, IC50 value of 0.47 μg/ml and IC90 value of 0.68 μg/ml. In the present study, the cells were treated with DDP at concentration of 0.5 and 1 μg/ml based on the pilot cytotoxicity study. MTT assay was performed to determine the viability of the cells after they were exposed to DDP for 4 days.
Furthermore, cell mixture composed of 10% p75 NTR+ Eca109-eGFP and 90% p75 NTR-Eca109 cells were cultured for 2 days and then exposed to 0.5 and 1 μg/ml DDP for 4 days respectively. The percentage of Eca109-eGFP cells was analyzed by flow cytometry.
copper accumulation assay
Isolated p75 NTR+ and p75 NTRcells were seeded into 6-well culture plates (1 × 10 5 cells/well), and incubated in an atmosphere containing 5% CO 2 for 24 h at 37°C. The medium was replaced with 1 ml fresh medium containing 2 μM 64 CuSO 4 , and the cells were incubated in 5% CO 2 for 0.5, 1.0, and 1.5 h at 37°C. After that, the plates were placed on ice and rinsed 3 times with 6 ml ice-cold PBS. Then 500 μl cell lysis buffer (0.1% Triton X-100 and 1% SDS in PBS) was added to the wells and the lysate was harvested by scraping the dish twice. The samples were transferred to tubes for γ counting on a Gamma 5500 B counter (Beckman Coulter, Inc., Fullerton, CA). Samples unexposed to 64 CuSO 4 were measured as control.
Xenograft tumorigenicity assay
Six to eight-week-old female congenitally immune-deficient nonobese diabetic/severe combined immune-deficiency (NOD/SCID) mice were randomly divided into different groups and maintained under standard conditions according to the institution's guidelines. Various numbers of p75 NTR+ and p75 NTR-Eca109 cells were suspended in 200 μl serum-free DMEM or in 200 μl serumfree DMEM/Matrigel (1:1), and injected subcutaneously into NOD/SCID mice. The mice were killed 10-16 weeks after tumor cell inoculation. Animals with no signs of tumor burden were further examined by autopsy to confirm that there was no tumor development.
Statistical analysis
For comparisons of gender, necrosis, distant metastasis and paraesophageal lymph node metastasis between p75 NTR positive and negative groups, chi-square test was performed. The correlation between p75 NTR expression and pathological grade was analyzed by Cochran-Mantel-Haenszel Statistics. Age of the patients and tumor diameter between two groups was compared by independent Student's t test. Other data obtained from experiments were expressed as mean ± SD ( ± s) and tested by Student's t test. Statistical analyses were conducted with SAS Statistical Software (version 9.1.3). P < 0.05 was considered significant.
Results
Expression of p75 NTR in ESCC specimens
As shown in Figure 1A , p75 NTR was found on the membrane of the basal cells in normal esophageal epithelium (NEE) and absent in the spinous layer. In well differentiated cases (WDC) and moderately differentiated cases (MDC), p75 NTR staining was apparent in the first few layers adjacent to the infiltrative margin of the tumors. In contrast, in poorly differentiated cases (PDC), p75 NTR was diffusely distributed.
In contrast to p75 NTR , involucrin staining was located in the spinous layer of NEE. Parallel sections from WDC and x Parallel sections from normal esophageal epithelial and ESCC specimen Figure 1 Parallel sections from normal esophageal epithelial and ESCC specimen. (A) In NEE, p75 NTR was located mainly in the basal layer; in WDC, p75 NTR positive staining was apparent in the first one to two layers from the infiltrative margin, areas exhibiting stratified squamous pearl formation were negative for p75 NTR ; in MDC, p75 NTR was expressed in wider range from the margin of the tumors; p75 NTR was diffusely distributed in PDC.(B) In NEE, basal cells coexpressed p75 NTR and p63, and very few p75 NTR+ cells expressed ki-67; in WDC and MDC, p75 NTR+ cells were at some distance surrounding involucrin + cells where most of the cells were coexpressed p63, and a small proportion of p75 NTR+ cells expressed ki-67; in PDC, few cells were positive for involucrin, more cells contained both p63 and p75 NTR , and their distribution was chaotic, a large number of p75 NTR+ cells stained brightly for ki-67. (Bars = 200 μm) MDC showed that p75 NTR+ cells were located at some distance from the terminally differentiated cells stained brightly for involucrin, and generally absent in the zones immediately surrounding the involucrin + cells. In PDC, there were few cells positive for involucrin, most of the cells were stained very brightly for p75 NTR . Distribution of the p75 NTR+ cells was irregular. In NEE, only a small proportion of p75 NTR+ cells expressed ki-67. In ESCC specimens, however, the proportion of p75 NTR and ki-67 coexpressing cells increased. In addition, p75 NTR and p63 had similar tissue distribution both in NEE and in ESCC specimens ( Figure 1B) .
The correlation between p75 NTR expression and various prognostic factors were investigated ( Table 1 ). p75 NTR expression correlated with age (P = 0.008), tumor diameter (P = 0.004) and pathological grade (P = 0.001). There was no significant correlation between p75 NTR expression and other factors such as gender, ki-67 index, necrosis, distant metastasis and paraesophageal lymph node metastasis.
Growth characteristics of p75 NTR+ cells
As shown in Figure 2 A~D, p75 NTR+ cells were detected in all 4 ESCC cell lines. The percentage of p75 NTR+ cells in Eca109, SHEC-1, SHEC-4 and SHEC-5 was 2.5%, 1.6%, 1.9% and 3.7%, respectively. To compare the growth characteristics of p75 NTR+ and p75 NTRcells, equal numbers of sorted cells were cultured in vitro for up to 6 weeks. The percentage of p75 NTR+ cells decreased progressively during the first three weeks and maintained steady thereafter. The cells derived from p75 NTR+ cells contained both p75 NTR+ and p75 NTRcells, whereas those from p75 NTRcells generated only p75 NTRcells.
In addition, the results of phenotypic analysis showed p75 NTR+ cells of different passages (total passages = 30) generated p75 NTR+ β1-integrin -, p75 NTR-β1-integrinand p75 NTR-β1-integrin + progenies (Figure 2E ), whereas p75 NTRcells generated only p75 NTRcells even in the 30th passage ( Figure 2F ).
Molecular characteristic of p75 NTR+ cells
As compared to p75 NTRcells, p75 NTR+ cells were shown to differentially express the following genes ( Figure 3 A~G) : (a) p63, a marker identified in keratinocyte stem cells [22] , was confined mainly to p75 NTR+ cells; (b) Bmi-1, a transcription repressor implicated in the regulation of self-renewal of normal and malignant stem cells [7, 23] , was significantly higher in p75 NTR+ cells; (c) copper transporter 1 gene (CTR1) [24] , a specific transporter of copper associated with DDP resistance, was confined mainly to p75 NTRcells. In addition, p75 NTR+ cells expressed lower levels of markers of differentiation such as involucrin, cytokeratin 13, β1-integrin and β4-integrin than p75 NTRcells.
Sphere-forming capacity of p75 NTR+ cells
Tumor cells were cultured in serum-free medium supplemented with growth factors. The formation of spheres were observed 10-15 days later. The percentage of p75 NTR+ cells was 68.3%, which was significantly higher than thatcultured in DMEM containg 10% FBS. Similar results were also obtained from SHEC-1 (62.7%), SHEC-4 (58.5%) and SHEC-5 (74.2%) ( Figure 4A ). Cells derived from p75 NTR+ cells contained both p75 NTR+ and p75 NTRcells, whereas those from p75 NTRcells generated only p75 NTRcells. In p75 NTR+ subpopulation, the percentage of p75 NTR+ cells declined time-dependently. In addition, p75 NTR+ cells could be serial passaged and generated p75 NTR+ β1-integrin -, p75 NTR-β1-integrinand p75 NTR-β1-integrin + progenies (E), whereas p75 NTRcells generated only p75 NTRcells in 5th passage (F). Sphere-forming capacity of p75 NTR+ cells isolated from Eca109 was examined. As shown in Figure 4B , single p75 NTR+ cell could proliferate in the serum-free medium. Three to 6 days after plating, the formation of spheres were observed. Two weeks later, the size of cell spheres became relatively large with the average diameter of 400 μm. Flow cytometry showed that the spheres contained both p75 NTR+ and p75 NTRcells ( Figure 4C ). Meanwhile, p75 NTR+ cells obtained from spheres did not expresse mature markers involucrin ( Figure 4D ) and cytokeratin 13 ( Figure 4E ). Under differentiating condition (10% fetal bovine serum supplementation), the floating p75 NTR+ cells could adhere to the dish and form a single layer of confluent cells expressing involucrin ( Figure 4F ) and cytokeratin 13 ( Figure 4G ). Furthermore, p75 NTR+ cells from these spheres were able to passage repeatedly and the percentage of p75 NTR+ cells from passage 10, passage 20 and passage 30 was 66.4%, 56.3% and 59.2%, respectively ( Figure 4H ). In contrast, p75 NTRcells were not able to form spheres.
Different gene mRNA expression in p75 NTR+ and p75 NTRsubpopulation
DDP sensitivity and 64 copper accumulation assays
Cell viability was measured by MTT assay 4 days after subjecting p75 NTR+ and p75 NTRcells to DDP. The OD 570 val-ues of p75 NTR+ cells were 0.34 ± 0.06 (0 μg/ml, n = 3), 0.27 ± 0.08 (0.5 μg/ml, n = 3) and 0.19 ± 0.05 (1 μg/ml, n = 3), whereas the values of p75 NTRcells were 0.36 ± 0.04 (0 μg/ ml, n = 3), 0.16 ± 0.06 (0.5 μg/ml, n = 3) and 0.03 ± 0.03 (1 μg/ml, n = 3). These results suggested that the viability of p75 NTRcells decreased significantly as compared to that of p75 NTR+ cells (P < 0.05, Figure 5A ).
The DDP resistance of p75 NTR+ cells was further examined by detecting enrichment of eGFP labeled p75 NTR+ cells cocultured with p75 NTRcells following exposure to DDP. It was demonstrated that DDP induced significant enrichment of p75 NTR+ cells and their percentage increased from 9.4% to 48.1% and 86.2%, respectively ( Figure 5B ). 
Xenograft tumorigenicity assay
Various numbers of sorted Eca109 cells were suspended in 200 μl serum-free DMEM and injected subcutaneously into NOD/SCID mice. The results showed that at least 2 × 10 3 p75 NTR+ cells or p75 NTRcells were needed to generate tumors. When transplanted cells were suspended in DMEM/Matrigel, the result showed that the lowest number of p75 NTR+ and p75 NTRcells to generate tumors was 500 and 2 × 10 3 , respectively ( Table 2 ).
Discussion
In the present study, we found that p75 NTR was confined to immature cells and absent in cells undergoing terminal differentiation in ESCC specimens. We also found the percentages of p75 NTR+ cells in the 4 ESCC cells lines ranged from 1.13% to 3.35%, which was similar to the percentages of CSCs as previously reported [1, 25, 26] .
In agreement with the previous report [21] , p75 NTR was confined to the basal layer in NEE. Although statistical analysis showed that positive rate of p75 NTR was not associated with lower pathological grade, histopathological analysis indicated that the number and distribution of p75 NTR+ cells altered depending on the degree of anaplasia in ESCC. In WDC, p75 NTR was confined to the surrounding basal-like cells which were at some distance from the centers of terminal differentiation. In MDC, the number of p75 NTR+ cells increased and their distribution became irregular with respect to the centers of terminal differentiation. In PDC, p75 NTR was diffusely distributed and there was virtually no relation between the distribution of p75 NTR+ cells and the small zones of terminal differentiation. Thus, both in NEE and ESCC, p75 NTR was mainly expressed in immature cells. Ki-67, a cell proliferationassociated nuclear antigen, was found in all stages of the cell cycle. Immunostaining for p75 NTR and ki-67 revealed that only a small proportion of p75 NTR+ cells expressed ki-67 in NEE, while the number of cancer cells coexpressing p75 NTR and ki-67 increased in ESCC. These results suggested that p75 NTR was expressed in cells that were proliferating or capable of proliferating. Furthermore, the distribution of p75 NTR in ESCC was similar to that of p63, a marker identified in keratinocyte stem cells [27, 28] . Taken together, it could be deduced that p75 NTR was expressed in undifferentiated cells. Toinvestigate the identity of p75 NTR+ cells as CSCs in ESCC, we further studied the biological characteristics of p75 NTR+ cells in Eca109 and 3 newly established cell lines.
Self-renewal capacity of p75 NTR+ cells
Self-renewal is one of the hallmarks of CSCs, which refers to the ability to form new stem cells with identical, and intact potential for proliferation, expansion, and differentiation. In the present study, our results revealed that p75 NTR+ cells could generate both p75 NTR+ and p75 NTRprogenies, but p75 NTRcells could generate only p75 NTRcells, suggesting a p75 NTR -associated cell hierarchy may exist in ESCC.
Sphere-forming ability in serum-free medium was used to reflect the self-renewal capacity of CSCs in a variety of studies and sphere cells were widely regarded as CSCs [7, [29] [30] [31] [32] . In the present study, we found ESCC cells could form cell spheres and the percentage of p75 NTR+ cells increased significantly. p75 NTR+ cells could be propagated undifferentiatedly cells in serum-free medium and differentiate into involucrin + and cytokeratin 13 + cells under differentiating conditions.
The higher expression of self-renewal associated gene and lower expression of differentiation markers also suggested that p75 NTR+ cells possessed the characteristics of ESCC CSCs.
Chemotherapy resistance of p75 NTR+ cells
DDP is an important chemotherapeutic agent for human esophageal carcinoma though resistance to it is likely to develop during the therapy [33] . Reduced DDP accumulation is considered as the most important feature [34, 35] . DDP enters cells much more slowly than most other classes of small-molecule anticancer agents. Current evidences showed that DDP uptake is mediated by CTR1, a major copper influx transporter in mammalian cells. Accumulated evidence indicates that CTR1 accountes for DDP uptake of cells in kinds of cancers including ovarian carcinoma, small-cell lung cancer, and prostate cancer.
The lower expression of CTR1 indicated p75 NTR+ cells might be more resistant to DDP than p75 NTRcells. In addition, we used 64 copper accumulation experiment to elucidate the DDP resistance because of the similar mechanism of DDP and copper uptake [36, 37] . The lower 64 copper accumulation also suggested that the low expression of CTR1 markedly impaired the influx of DDP in p75 NTR+ cells.
Meanwhile, the result of MTT assay showed that p75 NTR+ cells were more resistant to DDP than p75 NTRcells in all 4 esophageal carcinoma cell lines. Furthermore, the result of the enrichment assay offered the direct evidence that p75 NTR+ cells were more resistant to DDP since p75 NTR+ and p75 NTRcells were cocultured in the same condition.
Xenograft tumorigenicity of p75 NTR+
Finally, we injected 10 2 to 10 5 p75 NTR+ and p75 NTRcells isolated from Eca109 into NOD/SCID mice to determine whether p75 NTR+ cells possess higher tumorigenicity in immunocompromised mice than p75 NTRcells. Although tumors were generated at similar cell doses (more than 2 × 10 3 ) when p75 NTR+ cells or p75 NTRcells were suspended in DMEM, higher tumorigenicity was shown by p75 NTR+ cells when the transplanted cells were suspended in DMEM/Matrigel before inoculation. The results confirmed the tumorigenicity of p75 NTR+ cells in vivo. Although p75 NTRcells also exhibited some tumorigenic potential, this may be due to the meta-topical implantation of cells into a more permissive environment (e.g. subcutaneous site) compared to the environment of origin.
Conclusion
In summary, we found that (1) p75 NTR was mainly confined to immature cells capable of proliferation and absent from cells which were undergoing terminal differentiation in ESCC. (2) p75 NTR+ cells isolated from ESCC cell lines were able to generate both p75 NTR+ and p75 NTRcells, to form spheres in serum-free medium supplemented with growth factors, and to differentiate into mature esophageal squamous epithelial cells. and (3) p75 NTR+ cells were more resistant to DDP than p75 NTRcells. Our results demonstrated that p75 NTR+ cells possessed some characteristics of CSCs, namely, self-renewal and chemotherapy resistance.
